DELIVRA HEALTH BRANDS INC (DHB.CA) Stock Price, Quote, News and Overview
TSX-V:DHB - TSX Venture Exchange - CA24703H2019 - Common Stock - Currency: CAD
DHB.CA Quote, Performance and Key Statistics
TSX-V:DHB (7/18/2025, 7:00:00 PM)
0.23
-0.01 (-4.17%)
The current stock price of DHB.CA is 0.23 CAD. In the past year, price decreased by -23.33%.
DHB.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.67 | 3.21B | ||
| CRON.CA | CRONOS GROUP INC | 15.28 | 1.06B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 871.70M | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 6.57 | 781.48M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | 55 | 602.76M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 4.86 | 582.81M | ||
| ACB.CA | AURORA CANNABIS INC | 124.4 | 341.23M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 24.66 | 315.89M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 315.06M | ||
| HITI.CA | HIGH TIDE INC | N/A | 274.46M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 273.11M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | 33.5 | 269.10M |
Related stock screener links
About DHB.CA
Company Profile
Delivra Health Brands, Inc. is a cannabis company, which develops and provides lifestyle and wellness products to consumers and patients in regulated markets. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2010-02-02. The firm provides products that help with pain, sleep, anxiety, and performance through its acquired brands LivRelief and Dream Water. The company operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and its associated subsidiaries, and Delivra Corp. and its associated subsidiaries. Dream Water produces convenient, travel-friendly, single-serving 2.5oz liquid sleep shots, sleep powder packets that consumers can take with or without water and gummies. Its LivRelief brand offers relief for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and sports performance. The company has also added three new products to its portfolio of licensed infused products: Transdermal 1:1 Cream- 250mg CBD:250mg THC; Transdermal CBD Cream with Cooling - 500mg CBD, and Extra Strength Transdermal CBD Cream: 1200mg CBD.
Company Info
DELIVRA HEALTH BRANDS INC
Suite 404, 999 Canada Place
Vancouver BRITISH COLUMBIA CA
Employees: 27
Phone: 16044499280
DELIVRA HEALTH BRANDS INC / DHB.CA FAQ
What is the stock price of DELIVRA HEALTH BRANDS INC today?
The current stock price of DHB.CA is 0.23 CAD. The price decreased by -4.17% in the last trading session.
What is the ticker symbol for DELIVRA HEALTH BRANDS INC stock?
The exchange symbol of DELIVRA HEALTH BRANDS INC is DHB and it is listed on the TSX Venture Exchange exchange.
On which exchange is DHB.CA stock listed?
DHB.CA stock is listed on the TSX Venture Exchange exchange.
What is the price forecast or stock price prediction for DELIVRA HEALTH BRANDS INC stock?
9 analysts have analysed DHB.CA and the average price target is 0.73 CAD. This implies a price increase of 219.3% is expected in the next year compared to the current price of 0.23. Check the DELIVRA HEALTH BRANDS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DELIVRA HEALTH BRANDS INC worth?
DELIVRA HEALTH BRANDS INC (DHB.CA) has a market capitalization of 7.19M CAD. This makes DHB.CA a Nano Cap stock.
How many employees does DELIVRA HEALTH BRANDS INC have?
DELIVRA HEALTH BRANDS INC (DHB.CA) currently has 27 employees.
What are the support and resistance levels for DELIVRA HEALTH BRANDS INC (DHB.CA) stock?
DELIVRA HEALTH BRANDS INC (DHB.CA) has a support level at 0.22 and a resistance level at 0.24. Check the full technical report for a detailed analysis of DHB.CA support and resistance levels.
Is DELIVRA HEALTH BRANDS INC (DHB.CA) expected to grow?
The Revenue of DELIVRA HEALTH BRANDS INC (DHB.CA) is expected to grow by 4.45% in the next year. Check the estimates tab for more information on the DHB.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy DELIVRA HEALTH BRANDS INC (DHB.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DHB.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DHB.CA, evaluating the profitability, health, valuation and growth aspects
- DELIVRA HEALTH BRANDS INC (DHB.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DELIVRA HEALTH BRANDS INC (DHB.CA) Sales and EPS estimates to see what analysts future expectations are.
- DELIVRA HEALTH BRANDS INC (DHB.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DELIVRA HEALTH BRANDS INC (DHB.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- DELIVRA HEALTH BRANDS INC (DHB.CA) Stock Chart to make your own analysis
- DELIVRA HEALTH BRANDS INC (DHB.CA) Latest news and press-releases to stay up to date.
Does DELIVRA HEALTH BRANDS INC (DHB.CA) stock pay dividends?
DHB.CA does not pay a dividend.
When does DELIVRA HEALTH BRANDS INC (DHB.CA) report earnings?
DELIVRA HEALTH BRANDS INC (DHB.CA) will report earnings on 2025-10-06.
DHB.CA Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to DHB.CA. When comparing the yearly performance of all stocks, DHB.CA turns out to be only a medium performer in the overall market: it outperformed 51.4% of all stocks.
DHB.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to DHB.CA. DHB.CA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
DHB.CA Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.56% | ||
| ROE | -3.18% | ||
| Debt/Equity | 0.47 |
DHB.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to DHB.CA. The Buy consensus is the average rating of analysts ratings from 9 analysts.